SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) reports that the Chairman of its associate company, SG Austria, Prof. Walter H. Gunzburg, has been invited to present data about the proprietary encapsulation of living cell technology, in particular for the treatment of pancreatic cancer and other solid tumors, at the 8th Annual Meeting of the Organisation for Oncology and Translational Research (OOTR).
